Berenberg initiated coverage of Fresenius Medical (FMS) American depository receipts with a Buy rating and $25.60 price target The firm believes the company is receiving little credit for its earnings turnaround and deleveraging efforts.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS: